To compare the effectiveness of Dexmedetomidine and Magnesium Sulphate in their pre-emptive doses on postoperative pain relief after nasal surgery
Not Applicable
- Conditions
- Health Condition 1: J324- Chronic pansinusitis
- Registration Number
- CTRI/2019/03/018255
- Lead Sponsor
- Batra Hospital and Medical Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Weight 40-70 kgs
American Society of Anesthesiologists (ASA) grade I and II patients and ability to understand the Visual Analogue Scale(VAS)
Exclusion Criteria
Patient refusal for Inclusion into the study group.
Age less than 18 or more than 65 years.
Patients having a Body Mass Index (BMI) more than 30 kg/m2.
Patients with significant Cardio-respiratory diseases.
Patients having known allergy to study drug.
Patients having significant renal, hepatic, bleeding disorder, skeletal muscles disorder or any other neurological deficit.
Pregnant and Lactating women.
Patients with drug or alcohol abuse.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe and compare the efficacy of pre-emptive Dexmedetomidine and Magnesium Sulphate on postoperative pain relief after nasal surgeries under general anesthesia using 10 point 0-10cm Visual Analogue Scale (VAS) scoring.Timepoint: 30 minutes <br/ ><br>1 hour <br/ ><br>2 hours <br/ ><br>3 hours <br/ ><br>4 hours <br/ ><br>5 hours <br/ ><br>6 hours <br/ ><br>12 hours <br/ ><br>24 hours
- Secondary Outcome Measures
Name Time Method to observe drug side effects and satisfaction with the analgesia in patients undergoing nasal surgery.Timepoint: 30 minutes <br/ ><br>1 hour <br/ ><br>2 hours <br/ ><br>3 hours <br/ ><br>4 hours <br/ ><br>5 hours <br/ ><br>6 hours <br/ ><br>12 hours <br/ ><br>24 hours